All Articles

In December 2020, the FDA approved Margenza (margetuximab-cmkb), a new targeted therapy, for the treatment of patients with metastatic HER2-positive breast cancer, representing an important new option for patients with this type of breast cancer that continues to progress despite different treatments. Read More ›

To deal with grade 3 astrocytoma, a type of brain cancer, Matt Newman turned to writing personal e-mails to his friends and family as a way of dealing with the challenges he was facing. He shares his insights on the life lessons he has learned. Read More ›

Dr. Andrew Weinstein, a dermatologist, stresses the importance of monitoring skin changes regularly, giving advice and information regarding skin cancer, the most common cancer in the USA. Read More ›

Dana Dornsife, Founder and CEO of Lazarex Cancer Foundation, examines the importance of cancer clinical trials, noting that only about 5% of patients enrolled in clinical trials are from minority communities, something that needs to change. Read More ›

Judy Pearson describes her personal fight with cancer, providing a historical perspective on the war on cancer, which was officially launched in 1971, when cancer was believed to be contagious, showing just how far we’ve come, with new types of cancer therapies leading the way. Read More ›

In February 2021, the FDA approved Tepmetko (tepotinib), a new oral targeted therapy, for the treatment of all adults with metastatic non–small-cell lung cancer and MET exon 14 alterations. Tepmetko is the second MET inhibitor that has been approved by the FDA. Read More ›

In December 2020, the FDA approved Tagrisso (osimertinib) for adjuvant therapy (continued therapy to prevent cancer recurrence) after surgical removal of the tumor, in patients with non–small-cell lung cancer and EGFR exon 19 deletions or exon 21 L858R mutations. Tagrisso was previously approved for the treatment of other types of lung cancer. Read More ›

In December 2020, the FDA approved Orgovyx (relugolix), as the first oral hormone therapy for the treatment of men with advanced prostate cancer. This new drug may eliminate the need to visit the clinic for treatment, helping patients with cancer avoid unnecessary exposure during the pandemic. Read More ›

Ayesha Azam, VP of Medical Affairs at the Patient Access Network Foundation, explains the different ways that this organization provides financial assistance and grants for nearly 70 different medical conditions, including cancers and rare diseases. Find out if you qualify for financial support. Read More ›

Plunging from nightmare to nightmare, Serena was diagnosed with breast cancer, while her 39-year-old husband, Robert, had a stroke, which claimed his speech and movement, leaving him “trapped in a thoroughly trashed body.” Paying the medical bills added to their struggles during the pandemic. Read More ›